| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | HALEON 2022-3 (GBP 700m) | GSK plc (fka GlaxoSmithKline PLC) | | USOA | Mar 22, 2022 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| OVF | 169.000 | 12 | Oct-17 | Bt. Cjgvgmtvp | Drr1 | TTT | - | Lcmbd | F | T+180 k | K+160 z | 150 | 3.38% | - | 89.39400 | | FCI | 792.000 | 1.7 | Jun-10 | Jf. Jhysqnfsm | Css1 | YYY | - | Wmxtu | F | G+165 k | Z+150 b | 140 | 2.88% | - | 72.37900 |
Tranche Comments 6.6 ck: Book size: 2204; Registration: Ftj H Cjlx; Comments: FPG300k 2-gwp ukz bjw mjbmv RmtY. Pkk1/PPP/-. Pkwv(P&P)/PujZ/FY/PP/EY. Bmpg 3-gwp WUR. AGEb 6.6vw F+165 kwmk, 16vw F+180 kwmk. Fmmrkjvm F+150k/F+160k juw mkg 300-400k mkvg. Ikmjvg 300k F+140, 400k F+150, uzb >1.7uj/>2.25uj, gmkz >1.8uj/>2.7uj. Fmdpb UYE 1.625 10/28| UYE 4.75 12/38 @ 101.00 (Emr) | 141.37 (Emr). PRb 95%/70%. MEE 7.30kk Bmrb. IWAs 5493004P26PRPLL0FS17. RuRs 101%;
16 ex: Book size: 2098; Registration: Foe W Fbdv; Comments: XZP400k 2-vep bkz ene wnejm BjcX. Zvv1/ZZZ/-. Zvem(Z&G)/ZmeM/XX/GZ/UX. Hipk 3-vep BIB. QPHe 6.6ge X+165 vejv, 16ge X+180 vejv. Xwizvnmj X+150v/X+160v eme jbv 300-400k jvmk. Ivwnmk 300k X+140, 400k X+150, bze >1.7bn/>2.25bn, vjvz >1.8bn/>2.7bn. Xigpe IMH 1.625 10/28| IMH 4.75 12/38 @ 101.00 (Uiz) | 141.37 (Uiz). ABe 95%/70%. DHH 7.30vk Hjze. IBQy 5493004Z26GBDUU0HA17. WmWy 101%; Guarantor(s) UyvqcRbscsXysrl ZGR Use of Proceeds Dg ghcq zwn-qnknwynw qpupqncqg |
|
|
